BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16896947)

  • 41. Identification and functional significance of N-glycosylation of the 5-ht5A receptor.
    Dutton AC; Massoura AN; Dover TJ; Andrews NA; Barnes NM
    Neurochem Int; 2008 Feb; 52(3):419-25. PubMed ID: 17881091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
    Bubar MJ; Cunningham KA
    Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin/dopamine interaction in memory formation.
    González-Burgos I; Feria-Velasco A
    Prog Brain Res; 2008; 172():603-23. PubMed ID: 18772052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a novel 5-HT(4) receptor splice variant (r5-HT(4c1)) and preliminary characterisation of specific 5-HT(4a) and 5-HT(4b) receptor antibodies.
    Ray AM; Kelsell RE; Houp JA; Kelly FM; Medhurst AD; Cox HM; Calver AR
    Eur J Pharmacol; 2009 Feb; 604(1-3):1-11. PubMed ID: 19100256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors.
    Janoshazi A; Deraet M; Callebert J; Setola V; Guenther S; Saubamea B; Manivet P; Launay JM; Maroteaux L
    Mol Pharmacol; 2007 Jun; 71(6):1463-74. PubMed ID: 17325130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of novel splice variants of Adhesion G protein-coupled receptors.
    Bjarnadóttir TK; Geirardsdóttir K; Ingemansson M; Mirza MA; Fredriksson R; Schiöth HB
    Gene; 2007 Jan; 387(1-2):38-48. PubMed ID: 17056209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Desensitization of pre and post synaptic 5-HT-1A receptor responses following long term consumption of sugar rich diet: implications for sugar-induced obesity.
    Jabeen B; Haleem DJ
    Pak J Pharm Sci; 2008 Oct; 21(4):327-32. PubMed ID: 18930850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonin and epilepsy.
    Bagdy G; Kecskemeti V; Riba P; Jakus R
    J Neurochem; 2007 Feb; 100(4):857-73. PubMed ID: 17212700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of dorsal raphe nucleus 5-HT(1A) and 5-HT(2) receptors in tonic immobility modulation in guinea pigs.
    Ferreira MD; Menescal-de-Oliveira L
    Brain Res; 2009 Aug; 1285():69-76. PubMed ID: 19538947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in the brain serotonin satiety system in transgenic rats lacking brain angiotensinogen.
    Voigt JP; Raasch W; Hörtnagl H; Bader M; Fink H; Jöhren O
    J Neuroendocrinol; 2008 Feb; 20(2):182-7. PubMed ID: 18047554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of 5-HT1A and 5-HT7 receptors in Caco-2 cells and their role in the regulation of serotonin transporter activity.
    Iceta R; Mesonero JE; Aramayona JJ; Alcalde AI
    J Physiol Pharmacol; 2009 Mar; 60(1):157-64. PubMed ID: 19439818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.
    Chanrion B; Mannoury la Cour C; Gavarini S; Seimandi M; Vincent L; Pujol JF; Bockaert J; Marin P; Millan MJ
    Mol Pharmacol; 2008 Mar; 73(3):748-57. PubMed ID: 18083778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Receptor "families" for 5-hydroxytryptamine.
    Peroutka SJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S8-14. PubMed ID: 1369726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alternative mRNA splicing of G protein-coupled receptors.
    Markovic D
    Methods Enzymol; 2013; 520():323-35. PubMed ID: 23332707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiplicity of mechanisms of serotonin receptor signal transduction.
    Raymond JR; Mukhin YV; Gelasco A; Turner J; Collinsworth G; Gettys TW; Grewal JS; Garnovskaya MN
    Pharmacol Ther; 2001; 92(2-3):179-212. PubMed ID: 11916537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diverse signalling by 5-hydroxytryptamine (5-HT) receptors.
    Pauwels PJ
    Biochem Pharmacol; 2000 Dec; 60(12):1743-50. PubMed ID: 11108789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presynaptic 5-HT autoreceptors and the modulation of the release of 5-HT.
    Göthert M
    Clin Neuropharmacol; 1986; 9 Suppl 4():308-10. PubMed ID: 3567946
    [No Abstract]   [Full Text] [Related]  

  • 60. Regulation of serotonin 2C receptor pre-mRNA editing by serotonin.
    Schmauss C
    Int Rev Neurobiol; 2005; 63():83-100. PubMed ID: 15797466
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.